DLC1 and neoplasm: Next, using the Wilcoxon rank-sum test and the Kruskal–Wallis test, we discovered that the reduced expression of DLC1 was significantly related to tumor histological types (EEA vs. SEA, P = 8.2e−05), histological grade (G2 vs. G3, P = 0.03), clinical stage (P = 0.047), BMI (P = 0.036), diabetes (P = 0.018), event (P = 0.004), and menopause status (P = 8.6e−07) (Figures 4D–I).